富祥药业逆市飙升:产能保障+多元化产品驱动12%涨幅富祥药业(300497)凭借产能优势与多元化VC、FEC产品实现12%单日涨幅,逆市表现凸显成长潜力与投资者关注度提升。FUSHINE Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 18/11/2025, 07:01 One minute to read